NEW YORK – City of Hope, a Los Angeles-headquartered cancer treatment center, on Thursday said it has penned a three-year agreement with the Hospital Israelita Albert Einstein in Brazil to share its expertise through multi-disciplinary tumor boards and to explore precision oncology-focused research collaborations.
"This agreement marks another milestone moment, allowing City of Hope to extend its mission to eliminate cancer to a new continent," Harlan Levine, president of strategy and business ventures at City of Hope, said in a statement.
Experts at City of Hope will host educational webinars on topics, such as genetic testing, supportive care, and nursing, for residents in training and clinical staff at the Hospital Israelita Albert Einstein. City of Hope will also facilitate a virtual tumor board, in which physicians will discuss complex cases involving, for example, molecular testing and immunotherapy, as well as advances in care delivery.
"We will incorporate City of Hope's multidisciplinary approach to oncology precision medicine to address the cancer burden in Brazil," Sidney Klajner, president of Hospital Israelita Albert Einstein, said in a statement. "Together with City of Hope, we hope to collaborate on molecular diagnostics and innovative care advancements for the benefit of patients in Latin American and beyond."